Kelly Getz, PhD, MD
Kelly Getz, PhD, MPH, is an affiliate faculty member at the Center for Pediatric Clinical Effectiveness (CPCE), assistant professor of Epidemiology at the University of Pennsylvania’s Perelman School of Medicine Department of Biostatistics, Epidemiology and Informatics (DBEI), and a senior scholar at the Center for Clinical Epidemiology and Biostatistics (CCEB).
Dr. Getz’s research focuses on the treatment and supportive care of pediatric oncology patients, specifically on understanding and balancing associated therapeutic benefits and toxicity risks. Her overarching research goal is to develop and apply advanced methods to existing data resources in creative ways to enable observational research studies that will impact practice and improve both clinical outcomes and quality of life in pediatric cancer patients across diagnoses during treatment and into survivorship, with an emphasis in the emerging area of cardio-oncology research.
Dr. Getz’s work is supported by Alex’s Lemonade Stand Foundation’s Young Investigator award and a NHLBI K01 Career Development award. The latter study, “Early Treatment-Related Cardiotoxicity and Subsequent Outcomes in Pediatric Acute Myeloid Leukemia”, aims to leverage the strengths of multiple complementary data resources including clinical trial data, administrative billing data, echocardiographic studies, and large volume electronic health record data to address important questions across the cardiotoxicity risk continuum.
Dr. Getz completed a postdoctoral research fellowship in pediatric cancer epidemiology at CHOP’s Division of Oncology and CPCE under the supervision of Dr. Richard Alpenc. She earned her MPH and PhD at Boston University. She currently serves as assistant editor of the Journal of the American College of Cardiology (JACC) – CardioOncology.
Contact Dr. Getz at email@example.com.